PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
14-Oct-2020 Regeneron's Antibody Cocktail REGN-EB3 (Inmazeb®) is First FDA-Approved Treatment for Ebola (Zaire Ebolavirus) Regeneron Pharmaceuticals, Inc.
14-Oct-2020 FDA Approves First Treatment for Ebola Virus U.S. Food and Drug Administration
14-Oct-2020 The global digital therapeutics market is projected to be worth over USD 8.9 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis Roots Analysis
14-Oct-2020 ARISE-3 Phase 3 Trial Completion Expected by End of 2020 RegeneRx Biopharmaceuticals, Inc.
14-Oct-2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90 percent fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Bone Therapeutics
14-Oct-2020 New Functionality Added to Thermo Scientific SampleManager LIMS software for Manufacturing QA/QC and Contract Laboratories Thermo Fisher Scientific
14-Oct-2020 Formedix announces expansion to meet demands for clinical trial automation Formedix
14-Oct-2020 Amolyt Pharma annonce la première administration de l’AZP-3601 dans son essai clinique de phase 1 Andrew Lloyd Associates
14-Oct-2020 Protein Detection Pioneer, NanoMosaic, Prepares to Ship Its Powerful New Beta Platform in the Battle Against Cancer and Complex Diseases NanoMosaic
14-Oct-2020 CureLab Oncology Appoints The Honorable David J. Shulkin, M.D. to its Scientific Advisory Board CureLab Oncology Inc.
14-Oct-2020 Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to Enhance Development of Next Generation Antibody Radiation Conjugates Leveraging Its Proprietary AWE Platform Actinium Pharmaceuticals, Inc.
14-Oct-2020 Paragon Genomics Expands Portfolio of CleanPlex® SARS-CoV-2-Related NGS Tests Paragon Genomics, Inc.
14-Oct-2020 Polyphor receives CARB-X award of up to USD 18.44 million to support development of new antibiotic program Polyphor
14-Oct-2020 Bone Therapeutics’ allogeneic cell therapy product, ALLOB, shows 90 percent fusion rate at 24 months in Phase IIa study in lumbar spinal fusion Bone Therapeutics
13-Oct-2020 Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology Disc Medicine
13-Oct-2020 Soin Neuroscience Develops Novel Sacral Nerve Stimulator to Treat Bladder Incontinence Soin Neuroscience
13-Oct-2020 BioGX Announces FDA Emergency Use Authorization Submission of Extraction-Free Direct RT-PCR Test for COVID-19 BioGX
13-Oct-2020 Cambridge Research & Development Offers New Sanitizing Technology for Licensing - 'Self-Sanitizing Door Control System' to Combat Pathogenic Community Spread Cambridge Research & Development
13-Oct-2020 Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October Dynavax Technologies
13-Oct-2020 AlzeCure gets abstract on the NeuroRestore platform against Alzheimer's accepted for poster presentation at CTAD AlzeCure